Paragraph IV patent certification list has been updated by USFDA and now its having information up to 18th october 2010. The new updation includes paragraph IV filing against Doxepin Hydrochloride Tablets and Prednisolone Sodium Phosphate Orally Disintegrating Tablets.
For full list download click here
(Source: http://www.fda.gov/)
No comments:
Post a Comment